VL

Veronique Lecault

Chief Technology Officer

AbCellera


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
AbCellera
Industry
research
Employees
620.0
Seniority
C suite
Annual Revenue
28800000.0

Technologies

Route 53 Gmail Outlook Google Apps Amazon AWS Cloudflare DNS CloudFlare Hosting Microsoft Office 365 Hubspot Atlassian Cloud Leadfeeder React Sage Intacct StatusPage IO Greenhouse.io Nginx Bing Ads WordPress.org Vimeo Google Analytics Google Font API Google Tag Manager GoToWebinar Twitter Advertising Mobile Friendly Remote

Keywords

antibody discovery cell culture antibody therapies protein analysis microfluidic single cell analysis single cell genomics monoclonal antibody discovery cell enrichment cell screening cell recovery protein engineering t cell engagers bispecifics pharmaceuticals & biotechnology health care biotechnology research t-cell engagers clinical development pharmaceutical collaboration biologics manufacturing immunotherapy drug development gpcr-targeted antibodies metabolic conditions autoimmunity treatment solid tumor therapy integrated technology platform preclinical studies therapeutic peptides high-throughput screening antigen targeting innovative drug platforms patient health solutions biodiversity in antibody response cell therapy specialized proteins biopharmaceutical partnerships potent therapeutic candidates molecular biology biomedical engineering biotechnology innovations target validation therapeutics for cancer transmembrane proteins bioinformatics in targeting cutting-edge science high-throughput sequencing cd3-binding antibodies functional assays elisa techniques pharmacodynamics regenerative medicine large-scale expression systems clinical therapeutics immune cell engagers antibody-based treatments novel antibody formats biometric data in drug discovery drug candidate selection antibody diversification efficacy & safety biotherapeutics bioprocess optimization regulatory compliance in biopharma antibody engineering biotechnology antibody development ai-powered platform therapeutic antibodies immuno-oncology autoimmune disorders cancer treatment single-cell screening contract research organization clinical trials high unmet medical needs pharmaceutical collaborations advanced technology data science rapid response capabilities innovative therapeutics research partnerships healthcare solutions patient outcomes drug pipeline clinical-stage biotech antibody-based medicines therapeutic areas biopharmaceutical industry antibody therapeutics medical countermeasures health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans